Latest News

  • Growing in the midst of challenging Market Conditions

    Thursday, April 30, 2020
    Growing in the midst of challenging Market Conditions
    In the first quarter of this year, Covid-19 virus outbreak made Indonesia face challenges to increase the economic growth. Under these conditions, Kalbe posted net sales of Rp 5,796 billion for the first quarter of 2020, an increase of 8.0% compared to the same period last year of Rp 5,366 billion
  • KlikDokter in Partnership with the Indonesian Ministry of Health and BNPB: Conducting Rapid Test for COVID-19

    Saturday, April 18, 2020
    KlikDokter in Partnership with the Indonesian Ministry of Health and BNPB: Conducting Rapid Test for COVID-19

    Jakarta, April 18, 2020, PT Kalbe Farma Tbk (Kalbe) through its subsidiary KlikDokter conducted a risk assessment service in the form of a mass rapid test to reduce the rate of corona virus spread and expediting treatment for communities at risk of COVID-19 exposure. KlikDokter as an integrated digital health service platform has been appointed by the government through the Ministry of Health (Kemenkes) and the National Disaster Management Agency (BNPB) to assist the government in accelerating the handling and management of COVID-19. 

  • KALBE Provides COVID-19 Examination Services Using Reverse Transcription Polymerase Chain Reaction (RT-PCR) to Support the Government

    Thursday, April 16, 2020
    KALBE Provides COVID-19 Examination Services Using Reverse Transcription Polymerase Chain Reaction (RT-PCR) to Support the Government

    Jakarta, April 16, 2020, PT Kalbe Farma Tbk (Kalbe) through its subsidiary, KalGen-Innolab Clinical Laboratory, is ready to provide COVID-19 examination services using the Reverse Transcription Polymerase Chain Reaction (RT-PCR), the gold standard for COVID-19 examinations by detection of SARS-COV2 viral RNA that is acclaimed by Indonesian and international governments. KalGen Innolab is equipped with facilities of Biosafety Level 2+ (BSL2+) category, cutting-edge equipment, and trained human resources adhering to the requirements set by the Ministry of Health of the Republic of Indonesia through an official circular letter from the Minister of Health No.HK.02.01/Menkes/234/2020 regarding Guidelines for Laboratories conducting COVID-19 examination with RT-PCR. 

  • Enseval in Cooperation with the Indonesian Pharmacists Association Help Overcome COVID-19 Pandemic

    Tuesday, April 7, 2020
    Enseval in Cooperation with the Indonesian Pharmacists Association Help Overcome COVID-19 Pandemic

    Jakarta, April 7, 2020 - PT Kalbe Farma Tbk (Kalbe) through one of its subsidiary entities , PT Enseval Putera Megatrading Tbk (Enseval)  is assisting in the distribution of logistical aid from the Central Management Board of the Indonesian Pharmacist Association (PP IAI) to 34 Regional IAI Administrations throughout Indonesia. The logistical assistance from PP IAI takes the form of products and medical devices consisting of masks, hand-cleansers, plastic gloves, vitamins, and tea bags will be distributed to pharmacists on duty in pharmaceutical services who continue to perform services during the COVID-19 pandemic. The aid package was handed over by Drs (Apt) Nurul Falah Eddy Pariang, Chairperson of PP IAI; to Berty Argiyantari, Deputy Director of Logistics at PT Enseval Putra Megatrading Tbk at Enseval Office, Jakarta, to be distributed throughout Indonesia.
  • Growth Improvement in Sales

    Saturday, April 4, 2020
    Growth Improvement in Sales

    Jakarta, April 03, 2020 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced the audited results of the Company for the year 2019.

RSS
12345Last